Indication for and Impact of Switching from Pirfenidone to Nintedanib in Idiopathic Pulmonary Fibrosis

被引：0
|
作者：
Hogben, C. [1 ]
Kouranos, V. [2 ]
Kokosi, M. [3 ]
Renzoni, E. A. [4 ]
Chua, F. [5 ]
Wells, A. U. [6 ]
Maher, T. M. [3 ]
Molyneaux, P. L. [5 ]
George, P. M. [7 ]
机构：
[1] Royal Brompton & Harefield NHS Fdn Trust, Interstitial Lung Dis Unit, London, England
[2] Royal Brompton Hosp, Interstitial Lung Dis, London, England
[3] Royal Brompton Hosp, Interstitial Lung Dis Unit, London, England
[4] Imperial Coll, Royal Brompton Hosp, Interstitial Lung Dis Unit, London, England
[5] Royal Brompton & Harefield NHS Fdn Trust, London, England
[6] Royal Brompton Hosp, Resp, London, England
[7] Royal Brompton Hosp, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1635
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis
    Dempsey, Timothy M.
    Payne, Stephanie
    Sangaralingham, Lindsey
    Yao, Xiaoxi
    Shah, Nilay D.
    Limper, Andrew H.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1121 - 1128
  • [22] Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Manon Belhassen
    Faustine Dalon
    Maëva Nolin
    Eric Van Ganse
    Respiratory Research, 22
  • [23] Safety, Tolerability and Efficacy of Nintedanib Switched from Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Ikeda, S.
    Sekine, A.
    Baba, T.
    Katano, T.
    Matama, G.
    Aiko, N.
    Isomoto, K.
    Otoshi, R.
    Tabata, E.
    Shintani, R.
    Sadoyama, S.
    Yamakawa, H.
    Niwa, T.
    Nakagawa, H.
    Oda, T.
    Okuda, R.
    Kitamura, H.
    Komatsu, S.
    Hagiwara, E.
    Ogura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [24] Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis
    Roach, Katy
    Castells, E.
    Tongue, P.
    Elliott, G.
    Marshall, H.
    Richardson, M.
    Chachi, L.
    Mason, S.
    Sutcliffe, A.
    Bradding, P.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [25] Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone
    Donato Lacedonia
    Michele Correale
    Lucia Tricarico
    Giulia Scioscia
    Silvia Romana Stornelli
    Filomena Simone
    Massimo Casparrini
    Natale Daniele Brunetti
    Maria Pia Foschino Barbaro
    Internal and Emergency Medicine, 2022, 17 : 815 - 822
  • [26] Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone
    Lacedonia, Donato
    Correale, Michele
    Tricarico, Lucia
    Scioscia, Giulia
    Stornelli, Silvia Romana
    Simone, Filomena
    Casparrini, Massimo
    Brunetti, Natale Daniele
    Barbaro, Maria Pia Foschino
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (03) : 815 - 822
  • [27] Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib
    Zhang, Yingwei
    Jones, Kirk D.
    Achtar-Zadeh, Natalia
    Green, Gary
    Kukreja, Jasleen
    Xu, Biyun
    Wolters, Paul J.
    HISTOPATHOLOGY, 2019, 74 (02) : 341 - 349
  • [28] TREATMENT COST COMPARISON OF PIRFENIDONE VERSUS NINTEDANIB ON THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    Ho, R.
    Rufino, C.
    Lisondo, C.
    Alves, M.
    VALUE IN HEALTH, 2017, 20 (09) : A893 - A893
  • [29] Histopathologic and Molecular Analysis of Idiopathic Pulmonary Fibrosis Lungs from Patients Treated with Pirfenidone or Nintedanib
    Zhang, Yingwei
    Jones, Kirk
    Achtar-Zadeh, Natalia
    Kukreja, Jasleen
    Wolters, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [30] Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis Results of the INJOURNEY Trial
    Vancheri, Carlo
    Kreuter, Michael
    Richeldi, Luca
    Ryerson, Christopher J.
    Valeyre, Dominique
    Grutters, Jan C.
    Wiebe, Sabrina
    Stansen, Wibke
    Quaresma, Manuel
    Stowasser, Susanne
    Wuyts, Wim A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (03) : 356 - 363
12345